PANDEMIC

PM Sánchez: the Spanish Covid-19 vaccine will be ready before July

Pedro Sanchez (R) and the Spanish Socialist Workers' Party (PSOE) candidate for the presidency of the Andalusian Regional Government Juan Espadas attend the proclamation of Juan Espadas as the PSOE candidate for the Andalusian elections. Photo: Álex Cámara/dpa.
The head of the government visited the laboratories of the pharmaceutical company Rovi, which produces the Moderna vaccine against the coronavirus in Spain

Spanish Prime Minister Pedro Sánchez said on Saturday that Spain will have its own Covid-19 vaccine before the end of the first half of 2022.

The leader of the Spanish social democrats (PSOE) made this announcement during his speech at the proclamation of this party partner Juan Espadas as a candidate for the Andalusian elections.

Sanchez said that Spain will have its own vaccine next summer during his party's rally at the Palacio de Congresos in Granada. Earlier, in the same Andalusian city, the head of the government visited the laboratories of the pharmaceutical company Rovi, which produces the Moderna vaccine against the coronavirus in Spain.

During his visit to Rovi, Sánchez reaffirmed the Government's commitment to Science and Innovation. A commitment that, according to a government press release, is evident after the budget increase of 19% for 2022.

The government also highlighted the Spanish vaccination strategy, which described as "a great collective success." According to Sanchez, Spain today is a "world example" with 90% of the population with a full vaccination course.

A leading world producer

The Prime Minister also highlighted that Moderna has chosen Spain to consolidate its presence in Europe, the country being also one of the main producers of the Covid-19 vaccine worldwide.

The Moderna vaccine production line in collaboration with Rovi in Granada, once approved by the Spanish Agency for Medicines and Health Products (AEMPS), will be the first of a messenger RNA vaccine in our country.

It will produce 250 to 300 million booster doses per year, which would be equivalent to the doses needed to administer the booster dose to most of the citizens of the European Union.